At Janssen, we match cutting-edge science with world-class development and commercialization to bring treatment innovation to millions of patients suffering from cardiovascular, metabolic and retinal diseases.

Fully Integrated End-to-End Development

Once we determine that a compound has the potential to provide real clinical benefit, we dedicate our fully aligned resources to move forward with development. We harness our in-depth understanding of the disease and the target's biology, and factor in the real-life needs of clinicians and their patients in our process. We then conduct clinical trials that efficiently evaluate and validate the compound and meet the needs of our medical and regulatory stakeholders.

We operate with an intensity that characterizes the best of biotech, backed by the resources of a global healthcare company. Our global clinical research capabilities extend from the United States to Canada and Europe to growth markets in Asia Pacific, Latin America, parts of Eastern Europe and Japan. We use our broad development experience and flexible organization to bring development strategies together for novel treatments and platforms, and have dedicated teams that help successfully navigate the global regulatory environment.